CCP
AGN

Clough Capital Partners’s Allergan plc AGN Stock Holding History

Clough Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,300
Closed -$5.18M – 158
2017
Q3 		$5.18M Sell
25,300
-11,100
-30% -$2.58M 0.35% 69
2017
Q2 		$8.85M Buy
+36,400
New +$8.55M 0.61% 47
2016
Q4 		– Sell
-57,250
Closed -$13.2M – 210
2016
Q3 		$13.2M Buy
57,250
+25,100
+78% +$6.13M 0.69% 53
2016
Q2 		$7.43M Sell
32,150
-29,400
-48% -$6.78M 0.4% 81
2016
Q1 		$16.5M Buy
61,550
+8,950
+17% +$2.56M 0.78% 43
2015
Q4 		$16.4M Buy
+52,600
New +$15.7M 0.77% 46
2015
Q3 		– Sell
-76,600
Closed -$23.2M – 233
2015
Q2 		$23.2M Sell
76,600
-1,100
-1% -$328K 0.89% 38
2015
Q1 		$23.1M Buy
77,700
+14,100
+22% +$4.02M 0.77% 48
2014
Q4 		$16.4M Buy
+63,600
New +$15.9M 0.59% 67

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Clough Capital Partners's AGN Position: Q4 2017 in Review

Clough Capital Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 25,300 shares — an estimated $5.18M sold.

Clough Capital Partners first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $23.2M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Clough Capital Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Clough Capital Partners sold 25,300 Allergan plc shares in Q4 2017, an estimated $5.18M.
  • Clough Capital Partners first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • Clough Capital Partners's Allergan plc position peaked at $23.2M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Clough Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.